Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease.
Our objective in this article is to update dermatologists on the clinical management of malignant melanoma, including the role of sentinel node biopsy and options for the treatment of stage III and stage IV disease. The role of the dermatologist throughout the continuum of care is emphasized, and the essential partnership with medical oncology in recognizing promising new options for patients with advanced disease is examined.
Walsh
P
P
Department of Dermatology, Division of Medical Oncology, University of Colorado School of Medicine, Denver, USA.
Gibbs
P
P
Gonzalez
R
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D019496:Cancer Vaccines / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology*; D009367:Neoplasm Staging; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*
D019496:Cancer Vaccines; D007372:Interferons